Medibank (ASX:MPL) share price lifts as staff vaccine mandate hits headlines

Here's the latest news from Medibank Private.

| More on:
man receiving covid 19 vaccine moderna biontech

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medibank Private Ltd (ASX: MPL) share price is in the green today amid news the company will soon require nearly all its staff to be vaccinated against COVID-19.

Previously, only Medibank's front-line employees had to be vaccinated against COVID-19.

Medibank released the potentially divisive announcement yesterday and many media outlets reported on the changes after the ASX closed.

At the time of writing, the Medibank share price is $3.55, 0.85% higher than its previous close.

That's relatively in line with the broader market's performance this morning. Right now, the S&P/ASX 200 Index (ASX: XJO) has gained 0.2%. Meanwhile, the All Ordinaries Index (ASX: XAO) is up 0.3%.

Let's take a closer look at the latest news from Medibank.

Medibank extends employee vaccine mandate

The Medibank share price is gaining today amid headlines most of its staff are facing vaccination deadlines.

It follows fellow ASX-listed companies Crown Resorts Ltd (ASX: CWN) and Qantas Airways Limited's (ASX: QAN) decisions to do the same. Qantas declared all its staff must have a COVID-19 vaccination in August, while Crown mandated vaccination for employees last month.

Employees working in Medibank's retail or offices will soon need to be at least partially inoculated against COVID-19 to attend their workplaces or work events.

Those working in Medibank's retail segment must have had 2 doses of a COVID-19 vaccine by 15 December. All other employees face a deadline of 31 January 2022.  

Additionally, its executive leadership team and board of directors will be fully inoculated against COVID-19 by mid-October.

Employees who work completely from home are exempt from the mandate, as are those who can't get vaccinated for medical reasons.

Previously, Medibank required its frontline health workers to have at least one jab by 1 November, while those working in residential aged care had to have had their first dose by mid-September.

Commentary from management

Medibank's CEO David Koczka commented on the company's new vaccine mandate, saying:

As a company with more than 1,400 health professionals and a broader team focused on health and wellbeing each day, there is widespread understanding of the benefits of COVID vaccination across our business…

We've made this decision to help keep our people and customers safe and to support the immense effort of the nation's healthcare workers.

Medibank share price snapshot

The Medibank share price has been performing well on the ASX lately.

It has gained 16.6% since the start of 2021. It is also 36.8% higher than it was this time last year.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A red heart-shaped balloon floats up above the plain white ones, indicating the best shares.
Healthcare Shares

Heart tech firm's shares surge after huge capital raise

A strategic investor has also jumped on board.

Read more »

Lab technician in lab with a tray of specimens
Healthcare Shares

Has this ASX 200 stock just turned the corner after 7% surge?

Brokers think the volatile biotech share can sustain the rally this time.

Read more »

Green stock market graph with a rising arrow symbolising a rising share price.
Opinions

3 ASX shares tipped to climb over 100% in 2026

Analysts expect steep gains this year.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
Healthcare Shares

Top broker tips 57% upside for beaten-down Telix shares

A leading broker expects a big rebound in Telix shares in 2026.

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

Here's why Anteris shares are in a trading halt today

The company is undertaking a US$300m capital raising.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Telix shares in focus as the company meets guidance

More good news from the drug developer.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

What are the healthcare stocks where RBC Capital Markets thinks you can make money?

The top buys in the sector, listed.

Read more »